Specify a stock or a cryptocurrency in the search bar to get a summary
Enveric Biosciences Inc
ENVBEnveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Address: 4851 Tamiami Trail N, Naples, FL, United States, 34103
Analytics
WallStreet Target Price
8.32 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ENVB
Dividend Analytics ENVB
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ENVB
Stock Valuation ENVB
Financials ENVB
Results | 2019 | Dynamics |